AVITA Medical, Inc. Proceeds from Sale of Debt Securities, Available-for-sale
AVITA Medical, Inc. (RCEL) reported Proceeds from Sale of Debt Securities, Available-for-sale of $2.37 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt · last filed 2025-02-13
- AVITA Medical, Inc. proceeds from sale of debt securities, available-for-sale for the quarter ending 2023-12-31 was $0.00.
- AVITA Medical, Inc. proceeds from sale of debt securities, available-for-sale for the quarter ending 2023-09-30 was $2.40M.
- AVITA Medical, Inc. proceeds from sale of debt securities, available-for-sale for fiscal 2023 was $2.37M.
| Period end | Proceeds from Sale of Debt Securities, Available-for-sale 3 month | Proceeds from Sale of Debt Securities, Available-for-sale 6 month | Proceeds from Sale of Debt Securities, Available-for-sale 9 month | Proceeds from Sale of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $2.40M derived: sum of 2 quarters · filed 2025-02-13 | $2.37M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $2.40M 10-Q · filed 2023-11-09 | $2.37M 10-Q · filed 2024-11-07 |